The pathway of extracellular signal-regulated protein kinase (ERK1/2) in cancers, such as breast cancer, squamous cell carcinoma of head and neck cancer, could be activated by AURKA as well, thereby promoting the motility of cancer cells as well as proliferation and growth of cancer [16,17]. This evidence concerns the gene MAPK3 and breast carcinoma.